Risk identifying- The first element "identifying the risk" can be different in future because of Artificial intelligence. Now the AI working on decision making, crime prediction etc. And in some cases it predicts the market opportunities. Then it will be the best tool for identifying the risk.

Risk evaluation- risk evaluation could based on computer algorithms in future. Now it is working in only share markets but in future it can be helpful in evaluate the risk in other corporate fields.

Monitor risk- risk monitoring is technical work.it is doing by softwares those calculations are depend on human.AI can take the place of human for monitoring the risks.

We are seeing that how technology taking the place of mindmade equations in technology. In the future it can be possible that human only have to make the AI software for business then it will going on automatically. Due to technology depend business era businesses will be convert in technical game.

But this is the time for adapt the digitigation in businessess. Technology is better than human prediction in economically. And it is more beneficial with less harms like culture ruining.

This week we discussed the foundational importance of human rights to ethical choices and policies. What are some of the key human rights that intersect with your Course Project topic (My topic is Wind Power as Alternative Energy? How do you engage with human rights in your section draft that is due this week?

below is the draft that i need to submit this week in order for you to answer the question

this week i have and Individual Draft to take our and your team one step closer to your final Team Project. The draft should reflect the progress you have made in completing each milestone related to the Course Project in the earlier weeks, synthesize ideas you and your team members have developed, and highlight the key areas of analysis you have identified throughout the course.

the draft must also include a brief paragraph that explains the part of the Team Project (Alternative Energy) and where your draft will fit into the final paper.

give the reference

1.Name the enzyme(s) that is defected in methionine metabolism

2 .Define” fast” and “Slow” protein

3. What is the difference in absorption and metabolism of Fast and Slow protein?

4.Explain what happen to protein during the postabsorptive phase, discuss the hormones involved and their role and relations in protein synthesis

5. Mary is a 25 years old postoperative patient at the health clinic on campus. With an 80gm protein intake, and a 10-gram urea nitrogen output. Please calculate Mary’s nitrogen balance status. Is she in positive, negative, or at equilibrium? Based on her nitrogen status, explain what could be the possible reason for her nitrogen status

A accidental genetic mutation in the lab mice has occurred and affects the glycogen degradation pathway. Dr. Wilson is studying this unexpected mutation and has taken samples of their livers. What he found was excessive glycogen storage but the glycogen structure was unusual. There was a lot of glycogen but size of each glycogen molecule was smaller and each chain end had 4 glucose units (alpha 1,4 bonds) and then a SINGLE glucose attached as a branch point (alpha 1,6 bond) to the 5th carbon from the end. Which enzyme in the glycogen degradation pathway is not working?

As a new targeted anti-cancer drug ‘FCIC-17’ enters Phase III clinical trials, it is determined that the drug requires hepatic activation in order to elicit a therapeutic effect. Further studies identify that the sole enzyme involved in the activation of this drug is CYP2C19.

Questions:

a) Select ONE specific factor (from the categories environmental, genetic or physiological) that may contribute to inter-individual variability in the activation of ‘FCIC-17’, and explain the potential consequences of this variability in terms of treatment response and tolerability. (250 words; 5 marks)

b) Briefly discuss how this variability may be controlled for in clinical practice. (150 words; 3 mark)

BioChemistry Lab question:

Your PI would like to measure the concentration of alanine aminotransferase (ALT), a liver enzyme, in a homogenate of mouse liver. Your lab already has a bottle of ALT and a very specific and selective antibody that is known to bind to ALT and ALT only. What technique will you use to measure ALT in the liver homogenate? Why choose this/these technique/s? Briefly describe the results you would obtain from each technique.   

This is a lab question and so far in the class, we have done immunoblot, electroblotting, ELISA, Bradford Coomassie assay, protein ladder, SDS-PAGE, and Column chromatography.

you notice that a particular eukaryotic mRNA fails to undergo the process of capping. You, as a scientist come pu with multiple ways to help out this mRNA function. Out of al the methods there was one which was incorrect. Which one out of all your expt would not work...? A) you try to attach a compound to the MRNA that would get it out of the nucleus B) you try to stall the mRNA in the nucelus until the cell machinery can eventually start synthesizing a cap C) you try to increase the dose of the enzyme poly A polymerase D) you try to increase the levels of proteins that inhibit the function of exunucleases

Two charged proteins P1 and P2 are located at positions (1m,1m) and (-1m,1m) respectively on a Cartesian coordinate system. They have charges of 1.0 nC and -1.0 nV respectively. A key enzyme E1 which regulates an important biochemical pathway, is localed at the origin of the coordinate system.

1. compute the electrical potential V at the position of E1
2. Draw a vector diagram for the electrical field vector ETOT, at the position of E1.
3. show, or argue that the y component of the electrical field vector ETOT,Y at the position of E1, is equal to zero
4. Compute the electrical field vector ETOT, at the position of E1. Hint: ETOT is a vector!